Global Exocrine Pancreatic Insufficiency Market Research Report 2023

Report ID: 1982742 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Therapeutics
        1.2.3 Diagnostics
    1.3 Market by Application
        1.3.1 Global Exocrine Pancreatic Insufficiency Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Exocrine Pancreatic Insufficiency Market Perspective (2017-2028)
    2.2 Exocrine Pancreatic Insufficiency Growth Trends by Region
        2.2.1 Exocrine Pancreatic Insufficiency Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Exocrine Pancreatic Insufficiency Historic Market Size by Region (2017-2022)
        2.2.3 Exocrine Pancreatic Insufficiency Forecasted Market Size by Region (2023-2028)
    2.3 Exocrine Pancreatic Insufficiency Market Dynamics
        2.3.1 Exocrine Pancreatic Insufficiency Industry Trends
        2.3.2 Exocrine Pancreatic Insufficiency Market Drivers
        2.3.3 Exocrine Pancreatic Insufficiency Market Challenges
        2.3.4 Exocrine Pancreatic Insufficiency Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue
        3.1.1 Global Top Exocrine Pancreatic Insufficiency Players by Revenue (2017-2022)
        3.1.2 Global Exocrine Pancreatic Insufficiency Revenue Market Share by Players (2017-2022)
    3.2 Global Exocrine Pancreatic Insufficiency Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Exocrine Pancreatic Insufficiency Revenue
    3.4 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio
        3.4.1 Global Exocrine Pancreatic Insufficiency Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Exocrine Pancreatic Insufficiency Revenue in 2021
    3.5 Exocrine Pancreatic Insufficiency Key Players Head office and Area Served
    3.6 Key Players Exocrine Pancreatic Insufficiency Product Solution and Service
    3.7 Date of Enter into Exocrine Pancreatic Insufficiency Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Exocrine Pancreatic Insufficiency Breakdown Data by Type
    4.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Type (2017-2022)
    4.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Type (2023-2028)
5 Exocrine Pancreatic Insufficiency Breakdown Data by Application
    5.1 Global Exocrine Pancreatic Insufficiency Historic Market Size by Application (2017-2022)
    5.2 Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Exocrine Pancreatic Insufficiency Market Size (2017-2028)
    6.2 North America Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022)
    6.3 North America Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Exocrine Pancreatic Insufficiency Market Size (2017-2028)
    7.2 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022)
    7.3 Europe Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size (2017-2028)
    8.2 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022)
    8.3 Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Exocrine Pancreatic Insufficiency Market Size (2017-2028)
    9.2 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022)
    9.3 Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size (2017-2028)
    10.2 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022)
    10.3 Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Axcan Pharma
        11.1.1 Axcan Pharma Company Detail
        11.1.2 Axcan Pharma Business Overview
        11.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Introduction
        11.1.4 Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.1.5 Axcan Pharma Recent Development
    11.2 Aptalis Pharma
        11.2.1 Aptalis Pharma Company Detail
        11.2.2 Aptalis Pharma Business Overview
        11.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Introduction
        11.2.4 Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.2.5 Aptalis Pharma Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Introduction
        11.3.4 Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 Cilian
        11.4.1 Cilian Company Detail
        11.4.2 Cilian Business Overview
        11.4.3 Cilian Exocrine Pancreatic Insufficiency Introduction
        11.4.4 Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.4.5 Cilian Recent Development
    11.5 Nordmark Arzneimittel
        11.5.1 Nordmark Arzneimittel Company Detail
        11.5.2 Nordmark Arzneimittel Business Overview
        11.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Introduction
        11.5.4 Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.5.5 Nordmark Arzneimittel Recent Development
    11.6 Laboratoires Mayoly Spindler
        11.6.1 Laboratoires Mayoly Spindler Company Detail
        11.6.2 Laboratoires Mayoly Spindler Business Overview
        11.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Introduction
        11.6.4 Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022)
        11.6.5 Laboratoires Mayoly Spindler Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Exocrine Pancreatic Insufficiency Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Therapeutics
    Table 3. Key Players of Diagnostics
    Table 4. Global Exocrine Pancreatic Insufficiency Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Exocrine Pancreatic Insufficiency Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Exocrine Pancreatic Insufficiency Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Exocrine Pancreatic Insufficiency Market Share by Region (2017-2022)
    Table 8. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Exocrine Pancreatic Insufficiency Market Share by Region (2023-2028)
    Table 10. Exocrine Pancreatic Insufficiency Market Trends
    Table 11. Exocrine Pancreatic Insufficiency Market Drivers
    Table 12. Exocrine Pancreatic Insufficiency Market Challenges
    Table 13. Exocrine Pancreatic Insufficiency Market Restraints
    Table 14. Global Exocrine Pancreatic Insufficiency Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Exocrine Pancreatic Insufficiency Market Share by Players (2017-2022)
    Table 16. Global Top Exocrine Pancreatic Insufficiency Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exocrine Pancreatic Insufficiency as of 2021)
    Table 17. Ranking of Global Top Exocrine Pancreatic Insufficiency Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Exocrine Pancreatic Insufficiency Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Exocrine Pancreatic Insufficiency Product Solution and Service
    Table 21. Date of Enter into Exocrine Pancreatic Insufficiency Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Exocrine Pancreatic Insufficiency Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2017-2022)
    Table 25. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Type (2023-2028)
    Table 27. Global Exocrine Pancreatic Insufficiency Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2017-2022)
    Table 29. Global Exocrine Pancreatic Insufficiency Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Exocrine Pancreatic Insufficiency Revenue Market Share by Application (2023-2028)
    Table 31. North America Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Axcan Pharma Company Detail
    Table 42. Axcan Pharma Business Overview
    Table 43. Axcan Pharma Exocrine Pancreatic Insufficiency Product
    Table 44. Axcan Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 45. Axcan Pharma Recent Development
    Table 46. Aptalis Pharma Company Detail
    Table 47. Aptalis Pharma Business Overview
    Table 48. Aptalis Pharma Exocrine Pancreatic Insufficiency Product
    Table 49. Aptalis Pharma Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 50. Aptalis Pharma Recent Development
    Table 51. Eli Lilly Company Detail
    Table 52. Eli Lilly Business Overview
    Table 53. Eli Lilly Exocrine Pancreatic Insufficiency Product
    Table 54. Eli Lilly Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 55. Eli Lilly Recent Development
    Table 56. Cilian Company Detail
    Table 57. Cilian Business Overview
    Table 58. Cilian Exocrine Pancreatic Insufficiency Product
    Table 59. Cilian Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 60. Cilian Recent Development
    Table 61. Nordmark Arzneimittel Company Detail
    Table 62. Nordmark Arzneimittel Business Overview
    Table 63. Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Product
    Table 64. Nordmark Arzneimittel Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 65. Nordmark Arzneimittel Recent Development
    Table 66. Laboratoires Mayoly Spindler Company Detail
    Table 67. Laboratoires Mayoly Spindler Business Overview
    Table 68. Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Product
    Table 69. Laboratoires Mayoly Spindler Revenue in Exocrine Pancreatic Insufficiency Business (2017-2022) & (US$ Million)
    Table 70. Laboratoires Mayoly Spindler Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exocrine Pancreatic Insufficiency Market Share by Type: 2021 VS 2028
    Figure 2. Therapeutics Features
    Figure 3. Diagnostics Features
    Figure 4. Global Exocrine Pancreatic Insufficiency Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. Exocrine Pancreatic Insufficiency Report Years Considered
    Figure 9. Global Exocrine Pancreatic Insufficiency Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Exocrine Pancreatic Insufficiency Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Exocrine Pancreatic Insufficiency Market Share by Region: 2021 VS 2028
    Figure 12. Global Exocrine Pancreatic Insufficiency Market Share by Players in 2021
    Figure 13. Global Top Exocrine Pancreatic Insufficiency Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exocrine Pancreatic Insufficiency as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Exocrine Pancreatic Insufficiency Revenue in 2021
    Figure 15. North America Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Exocrine Pancreatic Insufficiency Market Share by Country (2017-2028)
    Figure 17. United States Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Exocrine Pancreatic Insufficiency Market Share by Country (2017-2028)
    Figure 21. Germany Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Exocrine Pancreatic Insufficiency Market Share by Region (2017-2028)
    Figure 29. China Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Exocrine Pancreatic Insufficiency Market Share by Country (2017-2028)
    Figure 37. Mexico Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Exocrine Pancreatic Insufficiency Market Share by Country (2017-2028)
    Figure 41. Turkey Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Exocrine Pancreatic Insufficiency Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Axcan Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 44. Aptalis Pharma Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 45. Eli Lilly Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 46. Cilian Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 47. Nordmark Arzneimittel Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 48. Laboratoires Mayoly Spindler Revenue Growth Rate in Exocrine Pancreatic Insufficiency Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler
Frequently Asked Questions
Exocrine Pancreatic Insufficiency report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Exocrine Pancreatic Insufficiency report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Exocrine Pancreatic Insufficiency report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

External Disk System

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More